Show simple item record

dc.contributor.authorYang, Meilheng
dc.contributor.authorMailhot, Genevieve
dc.contributor.authorMacKay, Carole A.
dc.contributor.authorMason-Savas, April
dc.contributor.authorAubin, Justin
dc.contributor.authorOdgren, Paul R.
dc.date2022-08-11T08:09:44.000
dc.date.accessioned2022-08-23T16:41:43Z
dc.date.available2022-08-23T16:41:43Z
dc.date.issued2005-11-24
dc.date.submitted2008-04-14
dc.identifier.citationBlood. 2006 Mar 15;107(6):2262-70. Epub 2005 Nov 22. <a href="http://dx.doi.org/10.1182/blood-2005-08-3365">Link to article on publisher's site</a>
dc.identifier.issn0006-4971 (Print)
dc.identifier.doi10.1182/blood-2005-08-3365
dc.identifier.pmid16304045
dc.identifier.urihttp://hdl.handle.net/20.500.14038/39940
dc.description.abstractOsteoclasts differentiate from hematopoietic precursors under systemic and local controls. Chemokines and receptors direct leukocyte traffic throughout the body and may help regulate site-specific bone resorption. We investigated bone gene expression in vivo during rapid osteoclast differentiation induced by colony-stimulating factor 1 (CSF-1) in Csf1-null toothless (tl/tl) rats. Long-bone RNA from CSF-1-treated tl/tl rats was analyzed by high-density microarray over a time course. TRAP (tartrate-resistant acid phosphatase)-positive osteoclasts appeared on day 2, peaked on day 4, and decreased slightly on day 6, as marrow space was expanding. TRAP and cathepsin K mRNA paralleled the cell counts. We examined all chemokine and receptor mRNAs on the arrays. CCL9 was strongly induced and peaked on day 2, as did its receptor, CCR1, and regulatory receptors c-Fms (CSF-1 receptor) and RANK (receptor activator of nuclear factor kappaB). Other chemokines and receptors showed little or no significant changes. In situ hybridization and immunohistochemistry revealed CCL9 in small, immature osteoclasts on day 2 and in mature cells at later times. Anti-CCL9 antibody inhibited osteoclast differentiation in culture and significantly suppressed the osteoclast response in CSF-1-treated tl/tl rats. While various chemokines have been implicated in osteoclastogenesis in vitro, this first systematic analysis of chemokines and receptors during osteoclast differentiation in vivo highlights the key role of CCL9 in this process.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16304045&dopt=Abstract">Link to article in PubMed</a>
dc.subjectAnimals
dc.subjectCathepsins
dc.subjectCell Differentiation
dc.subjectCell Proliferation
dc.subjectChemokines, CC
dc.subjectGene Expression Profiling
dc.subjectGlycoproteins
dc.subjectMacrophage Colony-Stimulating Factor
dc.subjectMacrophage Inflammatory Proteins
dc.subjectOsteoclasts
dc.subjectOsteopetrosis
dc.subjectOsteoprotegerin
dc.subjectRNA
dc.subjectRats
dc.subjectRats, Inbred Strains
dc.subjectReceptor, Macrophage Colony-Stimulating Factor
dc.subjectReceptors, CCR1
dc.subjectReceptors, Chemokine
dc.subjectReceptors, Cytoplasmic and Nuclear
dc.subjectReceptors, Tumor Necrosis Factor
dc.subjectCell and Developmental Biology
dc.subjectCell Biology
dc.titleChemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro
dc.typeArticle
dc.source.journaltitleBlood
dc.source.volume107
dc.source.issue6
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1274&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/275
dc.identifier.contextkey489612
refterms.dateFOA2022-08-23T16:41:43Z
html.description.abstract<p>Osteoclasts differentiate from hematopoietic precursors under systemic and local controls. Chemokines and receptors direct leukocyte traffic throughout the body and may help regulate site-specific bone resorption. We investigated bone gene expression in vivo during rapid osteoclast differentiation induced by colony-stimulating factor 1 (CSF-1) in Csf1-null toothless (tl/tl) rats. Long-bone RNA from CSF-1-treated tl/tl rats was analyzed by high-density microarray over a time course. TRAP (tartrate-resistant acid phosphatase)-positive osteoclasts appeared on day 2, peaked on day 4, and decreased slightly on day 6, as marrow space was expanding. TRAP and cathepsin K mRNA paralleled the cell counts. We examined all chemokine and receptor mRNAs on the arrays. CCL9 was strongly induced and peaked on day 2, as did its receptor, CCR1, and regulatory receptors c-Fms (CSF-1 receptor) and RANK (receptor activator of nuclear factor kappaB). Other chemokines and receptors showed little or no significant changes. In situ hybridization and immunohistochemistry revealed CCL9 in small, immature osteoclasts on day 2 and in mature cells at later times. Anti-CCL9 antibody inhibited osteoclast differentiation in culture and significantly suppressed the osteoclast response in CSF-1-treated tl/tl rats. While various chemokines have been implicated in osteoclastogenesis in vitro, this first systematic analysis of chemokines and receptors during osteoclast differentiation in vivo highlights the key role of CCL9 in this process.</p>
dc.identifier.submissionpathoapubs/275
dc.contributor.departmentDept of Cell Biology
dc.source.pages2262-70


Files in this item

Thumbnail
Name:
16304045.pdf
Size:
320.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record